NIALL O-DONNELL

Profile

First Name

: NIALL

Middle Name

:

Last Name

: O-DONNELL

Related Companies
Titles
Company Name
Related People
DIRECTOR
LYRIC PHARMACEUTICALS INC.
CASEY CUNNINGHAM, M. SCOTT HARRIS, JASON HONG, KEVIN LALANDE, DAVID WURTMAN, SANFORD ZWEIFACH
EXECUTIVE OFFICER
3X5 RIVERVEST FUND II, L.P.
N/A 3X5 PARTNERS MANAGERS II, L.P., N/A 3X5 PARTNERS MANAGERS II, LLC, N/A 3X5 RIVERVEST PARTNERS II, LLC, ANTHONY ARNERICH, JOHN P. MCKEARN, THOMAS C. MELZER, N/A RIVERVEST 3X5 MANAGERS II, L.P., N/A RIVERVEST 3X5 MANAGERS II, LLC, JAY W. SCHMELTER, NICHOLAS WALROD
EXECUTIVE OFFICER
ARCHER SEED FUND, L.P.
N/A ARCHER SEED PARTNERS, L.P., N/A ARCHER SEED PARTNERS, LLC, JOHN P. MCKEARN, THOMAS C. MELZER, JAY W. SCHMELTER
DIRECTOR
GENOA PHARMACEUTICALS, INC.
TIBA AYNECHI, LYN BARANOWSKI, DANIEL D. BURGESS, JILL CARROLL, SOFIA IOANNIDOU, MICHAEL J. KAMDAR, JONATHAN LEFF, JONATHAN LEFF, M.D., CASSANDRA GIANNA LUCA, ROBERT MITTENDORFF, PETER MOLDT, A. BRUCE MONTGOMERY, BRUCE MONTGOMERY, M.D., KETAN PATEL, HEATHER PRESTON, NAVEED SIDDIQI, MARK W. SURBER, PH.D., RICHARD G. VINCENT
EXECUTIVE OFFICER, DIRECTOR
RENEO PHARMACEUTICALS, INC.
SAMUEL AGRESTA, LON CARDON, PH.D., R. MICHAEL CARRUTHERS, MIKE CRUSE, ALEJANDRO DORENBAUM, M.D., GREGORY FLESHER, MICHAEL GREY, MICHAEL G. GREY, KENNETH HARRISON, DYLAN HARTLEY, VALERIE M. JANSEN, WENDY JOHNSON, JOHAN KORDEL, PH.D., JASON LEVERONE, ISAAC MANKE, ED MATHERS, EDWARD T. MATHERS, BALI MURALIDHAR, NIALL O-DONNELL, PH.D., ART PAPPAS, ANDREW JOHM PHILLIPS, NICHOLAS SACCOMANO, STACEY SELTZER, SCOTT WEINER
EXECUTIVE OFFICER
RIVERVEST VENTURE FUND IV, L.P.
JOHN P. MCKEARN, N/A RIVERVEST VENTURE PARTNERS IV, L.P., N/A RIVERVEST VENTURE PARTNERS IV, LLC, JAY W. SCHMELTER
DIRECTOR
CURZION PHARMACEUTICALS, INC.
SUSAN DUBE, MIKE GREY, JOHAN KORDEL, ED MATHERS, KYLE RASBACH
DIRECTOR
SPRUCE BIOSCIENCES, INC.
TIBA AYNECHI, PERCIVAL BARRETTO-KO, SIMPSON CAMILLA, RALPH WILLIAM CHARLTON III, DINA CHAYA, SAMIR GHARIB, MICHAEL GREY, JONAS HANSSON, RICHARD KING, BALI MURALIDHAR, CAMILLA SIMPSON, DANIEL SPIEGELMAN, JAVIER SZWARCBERG, KIRK WAYS
DIRECTOR
AVALYN PHARMA INC.
TIBA AYNECHI, LYN BARANOWSKI, DANIEL D. BURGESS, JILL CARROLL, SOFIA IOANNIDOU, MICHAEL J. KAMDAR, JONATHAN LEFF, JONATHAN LEFF, M.D., CASSANDRA GIANNA LUCA, ROBERT MITTENDORFF, PETER MOLDT, A. BRUCE MONTGOMERY, BRUCE MONTGOMERY, M.D., KETAN PATEL, HEATHER PRESTON, NAVEED SIDDIQI, MARK W. SURBER, PH.D., RICHARD G. VINCENT
DIRECTOR
MIRUM PHARMACEUTICALS, INC.
TIBA AYNECHI, ERIC BJERKHOLT, LAURA BREGE, LON CARDON, IAN CLEMENTS, SUSAN DUBE, WILLIAM C. FAIREY, LAURENT FISCHER, MICHAEL GREY, MICHAEL G. GREY, PATRICK HERON, PATRICK J. HERON, JONATHAN LEFF, LARA LONGPRE, ED MATHERS, EDWARD T. MATHERS, CHRIS PEETZ, CHRISTOPHER PEETZ, PETER RADOVICH, SAIRA RAMASASTRY, EDWIN JONATHAN TUCKER, PAMELA VIG, TIMOTHY WALBERT
EXECUTIVE OFFICER
RIVERVEST VENTURE FUND V, L.P.
JOHN P. MCKEARN, N/A RIVERVEST VENTURE PARTNERS V, L.P., N/A RIVERVEST VENTURE PARTNERS V, LLC, JAY W. SCHMELTER
DIRECTOR
SPARROW PHARMACEUTICALS, INC.
ROBERT JACKS, DAVID KATZ, DAVID AARON KATZ, NANNA L?NEBORG, JONATHAN ROOT, ZACH SCHEINER, PETER THOMPSON, KLAUS VEITINGER
DIRECTOR
WUGEN, INC.
MATTHEW COOPER, JAN K DAVIDSON, DREW DENNISON, BOSUN HAU, AYMAN KABAKIBI, DANIEL M KEMP, PETER KIENER, KEVIN LI, JOHN P MCKEARN, JOHN P. MCKEARN, NATALIE MOUNT, BALI MURALIDHAR, KUMAR SRINIVASAN, CHERRY THOMAS, KEITH VENDOLA
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-09-08
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2025-08-22 
2025-07-01
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2025-06-20 
2024-04-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2024-04-10 
2023-10-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-09-22 
2021-03-24
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2020-10-06 
2020-12-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-12-22 
2020-08-14
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NOT APPLICABLE 
Equity 
2020-02-19 
2020-05-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-04-24 
2020-02-28
D
Link
BIOTECHNOLOGY 
 
NOT APPLICABLE 
Equity 
2020-02-19 
2019-07-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2019-03-26 
2018-10-09
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2017-12-15 
2018-01-08
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-12-22 
2017-05-24
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-13 
2017-04-24
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-02-11 
2017-03-24
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-13 
2016-12-13
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2016-11-30 
2016-11-17
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2015-11-19 
2015-02-26
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-02-11